[Maternal complications from tocolytic treatment with beta-mimetics. Three cases of pulmonary edema].
We report three cases of pulmonary edema associated with prolonged intravenous tocolytic therapy with beta 2-adrenergic agonists among patients with multiple pregnancies. Although beta 2-adrenergic agonists may have direct myocardial side-effects, the underlying pathophysiologic mechanisms are mainly noncardiogenic. The most important one appears to be the fluid overload, related to amounts of fluids given intravenously and to direct result of beta-sympathomimetic therapy on renal excretion of sodium and water. Neonatal benefit of prolonged tocolytic therapy remains hypothetical. If this strategy is used, the prevention of cardiovascular adverse effects requires an intensive maternal supervision, especially in case of multiple pregnancy, the use of beta 2-adrenergic agonists in concentrated solution in order to reduce the amounts of fluids given intravenously, and the association with progesterone therapy which can reduce the infusion rate and the duration of tocolytic therapy.
Hourdequin
P
P
Clinique Obstétricale et Gynécologique, Hôpital Maison-Blanche, Centre Hospitalier Universitaire de Reims.
Bednarczyk
L
L
Gabriel
R
R
Harika
G
G
Quereux
C
C
Wahl
P
P
D000318:Adrenergic beta-Agonists / Q000009:adverse effects*; D000328:Adult; D005260:Female; D006801:Humans; D007262:Infusions, Intravenous; D007744:Obstetric Labor Complications / Q000139:chemically induced*; D011247:Pregnancy; D011272:Pregnancy, Multiple; D011654:Pulmonary Edema / Q000139:chemically induced*; D012099:Reproductive Techniques; D012312:Ritodrine / Q000009:adverse effects*; D015149:Tocolytic Agents / Q000009:adverse effects*
D000318:Adrenergic beta-Agonists; D015149:Tocolytic Agents; D012312:Ritodrine